News

2017 Jul 11

‘Fusion genes’ drive formation and growth of colorectal cancer

Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Lukas Dow, Ph.D. Read more

2017 Jul 10

Investigating a loss to discover a win for prostate cancer patients

Michael Augello, Ph.D., has received a grant to investigate the role of CHD1 loss in prostate cancer progression. Read more

2017 Jul 08

‘Nurse of the Year’ opened up her home to a cancer patient

Feature honoring oncology nurse Karen Pekle. Read more

2017 Jul 01

When the Doctor Becomes a Patient

A cancer diagnosis helped Lisa Roth, M.D., look at healing in a whole new way Read more

2017 Jun 30

Convection-enhanced delivery appears safe in pediatric diffuse intrinsic pontine glioma

Mark Souweidane, M.D., reports on his unique drug delivery system to treat the rare pediatric brain tumor DIPG. Read more

2017 Jun 28

Weill Cornell uses HL7 to help integrate structured genomic data into Epic EHR

Moving beyond the PDF, Weill Cornell Medicine enables precision medical records for advanced oncology. Read more

Cancer immunologist Sandra Demaria, M.D., of the Meyer Cancer Center, is using radiation to transform tumors into personalized vaccines

2017 Jun 26

Enzyme key to triggering anti-cancer immune response

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy’s ability to trigger an immune response against cancer, according to Sandra Demaria and colleagues. Read more

2017 Jun 22

Expert sheds light on lesser-known T-cell lymphoma subtypes

Adult T-cell lymphoma/leukemia (ATLL), a rare subtype of peripheral T-cell lymphoma, presents very differently and can be more prevalent in certain worldwide demographics compared with others, explains Adrienne A. Phillips, M.D. Read more

2017 Jun 22

A parting shot at cancer

Postmortem tissue donation through the precision medicine program is helping to advance cancer research in unprecedented ways. Read more

2017 Jun 21

Enzyme Regulates the Ability of Radiation Therapy to Activate Anti-Tumor Immunity

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy’s ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study. Their... Read more

2017 Jun 21

Could a blood test predict how cancer spreads in children?

David Lyden, M.D., Ph.D., discusses his work trying to isolate tumor exosomes as predictors of metastasis. Read more

2017 Jun 21

Injections of cash for young blood cancer researchers

Four young scientists have received fellowships to pursue lymphoma and leukemia research. Read more

Dr. Eloise Chapman-Davis and Dr. Juan R. Cubillos-Ruiz

2017 Jun 20

Ovarian Cancer: Overcoming Obstacles to Immunotherapy

Juan R. Cubillos-Ruiz, Ph.D., and Eloise Chapman-Davis, M.D., discuss the latest treatments for ovarian cancer. Read more

2017 Jun 20

Global trends in gastroesophageal cancers

Manish Shah, M.D., joins a group of international experts in gastroesophageal cancers for a discussion about global trends in gastric cancers. Read more

2017 Jun 20

Chomping at the bit: Harnessing autophagy to kill cancer

Lorenzo Galluzzi, Ph.D, is investigating the unrealized potential of autophagy modulation for cancer therapy. Read more

Tessa Cigler, M.D. uses cold caps to preserve hair during chemotherapy

2017 Jun 19

Evidence builds for scalp cooling

Two-thirds of patients who underwent scalp cooling treatment during breast cancer chemotherapy retained their hair, according to a study by Tessa Cigler, M.D. Read more

2017 Jun 19

Researchers develop first-ever human tissue platform to test drugs for colon cancer

The first-ever “disease in a Petri dish” platform that models human colon cancer derived from stem cells has been developed by a team led by Todd Evans and Shuibing Chen. Read more

2017 Jun 15

Novel Regimens Explored for Rare DLBCL Subtypes

Sarah Rutherford, M.D., discusses therapy for double-hit and double-protein expressor lymphomas. Read more

Innovation from Weill Cornell Medicine scientists + the best medical care from NewYork-Presbyterian doctors puts Meyer Cancer Center first in NYC cancer care.

2017 Jun 14

How mixed reality is transforming collaborative cancer research

Computational biologist Alex Sigaras explains how Weill Cornell Medicine is using virtual and "mixed" reality to enhance cancer research. Read more

2017 Jun 09

‘How long have I got?’: Why many cancer patients don’t have answers

Holly Prigerson and Ronald Adelman discuss the importance of honest and frank communication between oncologists and their patients. Read more

News

‘Fusion genes’ drive formation and growth of colorectal cancer

Investigating a loss to discover a win for prostate cancer patients

‘Nurse of the Year’ opened up her home to a cancer patient

When the Doctor Becomes a Patient

Convection-enhanced delivery appears safe in pediatric diffuse intrinsic pontine glioma

Weill Cornell uses HL7 to help integrate structured genomic data into Epic EHR

Enzyme key to triggering anti-cancer immune response

Expert sheds light on lesser-known T-cell lymphoma subtypes

A parting shot at cancer

Enzyme Regulates the Ability of Radiation Therapy to Activate Anti-Tumor Immunity

Could a blood test predict how cancer spreads in children?

Injections of cash for young blood cancer researchers

Ovarian Cancer: Overcoming Obstacles to Immunotherapy

Global trends in gastroesophageal cancers

Chomping at the bit: Harnessing autophagy to kill cancer

Evidence builds for scalp cooling

Researchers develop first-ever human tissue platform to test drugs for colon cancer

Novel Regimens Explored for Rare DLBCL Subtypes

How mixed reality is transforming collaborative cancer research

‘How long have I got?’: Why many cancer patients don’t have answers

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters